ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,670Medicare Part D Prescriptions Filled, Including Refills

Rank: 142 out of 890

$826K Total Retail Price of All Prescriptions

Rank: 91 out of 890

604 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 604 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 9,066 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 833 670 1 1
SIMVASTATIN 659 459 2 5
ATORVASTATIN CALCIUM 622 474 3 13
METFORMIN HCL 525 354 4 6
LISINOPRIL 495 311 5 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 327 216 6 21
HYDRALAZINE HCL 281 182 7 100
CLONIDINE HCL 276 186 8 35
DIOVAN 248 198 9 33
CRESTOR 232 174 10 25
FUROSEMIDE 231 161 11 7
EVISTA 228 202 12 182
CLOPIDOGREL 228 179 12 28
METOPROLOL SUCCINATE 221 138 14 17
DIOVAN HCT 218 188 15 48
CARVEDILOL 218 166 15 22
ACTOS 199 145 17 88
TRAMADOL HCL 193 143 18 16
KLOR-CON M20 185 135 19 72
HYDROCHLOROTHIAZIDE 181 139 20 9
PLAVIX 173 138 21 42
NEXIUM 162 106 22 14
LIPITOR 157 121 23 77
JANUVIA 140 115 24 59
LEVOTHYROXINE SODIUM 136 114 25 2
HUMALOG MIX 75-25 127 76 26 264
SINGULAIR 127 68 26 79
OMEPRAZOLE 121 85 28 8
MONTELUKAST SODIUM 119 70 29 130
POTASSIUM CHLORIDE 110 70 30 11
BENICAR HCT 104 68 31 166
METOPROLOL TARTRATE 94 68 32 15
BYSTOLIC 87 52 33 86
KLOR-CON 10 86 44 34 189
FELODIPINE ER 82 52 35 187
NOVOLOG MIX 70-30 81 58 36 313
TRAMADOL HCL-ACETAMINOPHEN 80 40 37 117
ACTONEL 76 68 38 263
BENICAR 70 44 39 180
TAMSULOSIN HCL 69 58 40 32
PIOGLITAZONE HCL 68 57 R 41 211
ACETAMINOPHEN-CODEINE 67 48 S3 42 124
GLYBURIDE MICRONIZED 65 58 R 43 203
INSULIN SYRINGE 65 56 43 99
AMLODIPINE BESYLATE-BENAZEPRIL 64 64 45 41
INDOMETHACIN 64 41 R 45 275
MECLIZINE HCL 64 58 45 97
GLIMEPIRIDE 61 51 48 27
PREDNISONE 61 30 48 47
DOXYCYCLINE HYCLATE 61 24 48 89
ONGLYZA 59 42 51 146
QUINAPRIL HCL 59 24 51 116
DIGOXIN 57 42 53 65
ADVAIR DISKUS 56 47 54 52
NAPROXEN 54 51 55 84
PRAVASTATIN SODIUM 51 42 56 10
FAMOTIDINE 51 39 56 90
DILTIAZEM 24HR ER 50 39 58 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.